American Century Companies Inc. lifted its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 23.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 2,242,829 shares of the technology company's stock after acquiring an additional 426,911 shares during the period. American Century Companies Inc. owned approximately 1.99% of Amdocs worth $205,219,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently made changes to their positions in DOX. Farther Finance Advisors LLC increased its position in Amdocs by 17.5% in the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after acquiring an additional 147 shares in the last quarter. Corbyn Investment Management Inc. MD increased its position in Amdocs by 0.4% in the 1st quarter. Corbyn Investment Management Inc. MD now owns 38,866 shares of the technology company's stock valued at $3,556,000 after acquiring an additional 152 shares in the last quarter. PNC Financial Services Group Inc. increased its position in Amdocs by 3.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 5,247 shares of the technology company's stock valued at $480,000 after acquiring an additional 177 shares in the last quarter. Denali Advisors LLC increased its position in Amdocs by 3.6% in the 1st quarter. Denali Advisors LLC now owns 5,810 shares of the technology company's stock valued at $532,000 after acquiring an additional 200 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in Amdocs by 55.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after acquiring an additional 208 shares in the last quarter. 92.02% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms have weighed in on DOX. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Wolfe Research began coverage on shares of Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating for the company. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, Amdocs presently has a consensus rating of "Buy" and an average price target of $105.33.
Get Our Latest Stock Report on Amdocs
Amdocs Trading Down 0.3%
NASDAQ DOX traded down $0.2620 during trading on Wednesday, reaching $87.1880. 405,649 shares of the stock traded hands, compared to its average volume of 716,029. The firm has a market cap of $9.84 billion, a price-to-earnings ratio of 17.68, a price-to-earnings-growth ratio of 1.59 and a beta of 0.51. The stock's 50-day moving average price is $89.50 and its 200 day moving average price is $88.77. The company has a quick ratio of 1.16, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a fifty-two week low of $78.61 and a fifty-two week high of $95.41.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The business's revenue for the quarter was down 8.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.62 earnings per share. Analysts predict that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a dividend of $0.527 per share. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.4%. Amdocs's payout ratio is currently 42.80%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.